The study also highlights that FOXA1 and FOXA2 have the same or opposite roles in several mammalian stages, which provides a theoretical basis for the future treatment of metabolic diseases, neurodegenerative diseases, and cancers by targeting FOXA1 and FOXA2. The gene discussed is FOXA1; the disease is neurodegenerative disease.